|
Idiopathic thrombocytopenic purpura (ITP) is the condition of having a low platelet count (thrombocytopenia) of no known cause (idiopathic). As most causes appear to be related to antibodies against platelets, it is also known as immune thrombocytopenic purpura. Although most cases are asymptomatic, very low platelet counts can lead to a bleeding diathesis and purpura. The International Statistical Classification of Diseases and Related Health Problems (most commonly known by the abbreviation ICD) provides codes to classify diseases and a wide variety of signs, symptoms, abnormal findings, complaints, social circumstances and external causes of injury or disease. ...
The following codes are used with International Statistical Classification of Diseases and Related Health Problems. ...
// C00-D48 - Neoplasms (C00-C14) Malignant neoplasms, lip, oral cavity and pharynx (C00) Malignant neoplasm of lip (C01) Malignant neoplasm of base of tongue (C02) Malignant neoplasm of other and unspecified parts of tongue (C03) Malignant neoplasm of gum (C04) Malignant neoplasm of floor of mouth (C05) Malignant neoplasm of...
The International Statistical Classification of Diseases and Related Health Problems (most commonly known by the abbreviation ICD) provides codes to classify diseases and a wide variety of signs, symptoms, abnormal findings, complaints, social circumstances and external causes of injury or disease. ...
The following is a list of codes for International Statistical Classification of Diseases and Related Health Problems. ...
The Mendelian Inheritance in Man project is a database that catalogues all the known diseases with a genetic component, and - when possible - links them to the relevant genes in the human genome. ...
The Disease Bold textDatabase is a free website that provides information about the relationships between medical conditions, symptoms, and medications. ...
eMedicine is an online clinical medical knowledge base that was founded in 1996. ...
Medical Subject Headings (MeSH) is a huge controlled vocabulary (or metadata system) for the purpose of indexing journal articles and books in the life sciences. ...
A 250 ml bag of newly collected platelets. ...
Thrombocytopenia (or -paenia, or thrombopenia in short) is the presence of relatively few platelets in blood. ...
Each antibody binds to a specific antigen; an interaction similar to a lock and key. ...
In medicine, a disease is asymptomatic when it is at a stage where the patient does not experience symptoms. ...
In medicine (hematology), a bleeding diathesis is a propensity to bleeding (hemorrhage) due to a defect in the system of coagulation. ...
Purple discolorations on the skin caused by bleeding underneath the skin. ...
Signs and symptoms
ITP occurs most often in women over 40 years of age with the male female ratio about 1:1.5. It may be acute, lasting for 6 months or less, or chronic, lasting for over a year. The acute type is more often seen in children and will cure itself in more than 80% of cases. The chronic type is more commonly seen in adults and it tends to get worse as the disease progresses. Occasionally, ITP patients suffer from petechiae, bruising, nosebleeds, and bleeding gums; this is the characteristic pattern of bleeding in platelet disorders. Bleeding normally does not occur unless the platelet count is very low (below about 10,000 per mm3, compared to a normal range of 150,000–400,000 per mm3). minor Petechia A petechia (IPA pronunciation: ), plural petechiae (IPA pronunciation: ) is a small red or purple spot on the body, caused by a minor hemorrhage (broken capillary blood vessels). ...
A bruise or contusion or ecchymoses is a kind of injury, usually caused by blunt impact, in which the capillaries are damaged, allowing blood to seep into the surrounding tissue. ...
A nosebleed or nosebleedage, medically known as epistaxis, is the relatively common occurrence of hemorrhage (bleeding) from the nose, usually noticed when it drains out through the nostrils. ...
The gingiva, or gums, consist of the tissue surrounding the roots of the teeth and covering the jawbone. ...
Subarachnoid and intracerebral hemorrhage are very serious possible complications of this disease. Fortunately, these are rare in patients who are being treated. A subarachnoid hemorrhage (SAH) is bleeding into the subarachnoid space surrounding the brain, i. ...
...
Pathogenesis In many cases, the cause is not actually idiopathic but autoimmune, with antibodies against platelets being detected in approximately 60% of patients. Most often these antibodies are against platelet membrane glycoproteins IIb-IIIa or Ib-IX, and are of the IgG type. The coating of platelets with IgG renders them susceptible to opsonization and phagocytosis by splenic macrophages. Idiopathic means arising spontaneously or from an obscure or unknown cause. ...
Autoimmune diseases arise from an overactive immune response of the body against substances and tissues normally present in the body. ...
Wikipedia does not yet have an article with this exact name. ...
A glycoprotein is a macromolecule composed of a protein and a carbohydrate (an oligosaccharide). ...
Schematic of antibody binding to an antigen An antibody is a protein complex used by the immune system to identify and neutralize foreign objects like bacteria and viruses. ...
An opsonin is any molecule that acts as a binding enhancer for the process of phagocytosis. ...
Phagocytosis is a form of endocytosis wherein large particles are enveloped by the cell membrane of a (usually larger) cell and internalized to form a phagosome, or food vacuole. ...
The spleen is an organ of the lower abdomen, where it functions in the destruction of old red blood cells and holding a reservoir of blood. ...
A macrophage of a mouse stretching its arms to engulf two particles, possibly pathogens Macrophages (Greek: big eaters, makros = long, phagein = eat) are white blood cells, more specifically phagocytes, acting in the nonspecific defense as well as the specific defense system of vertebrate animals. ...
The IgG autoantibodies are also thought to damage megakaryocytes, the precursor cells to platelets, but this is thought to contribute only slightly to the decrease in platelet numbers. Recent evidence suggests that the stimulus for autoantibody production in ITP is due to abnormal T helper cells reacting with platelet antigens on the surface of antigen presenting cells. This importamt finding suggests that therapies directed towards T cells may be effective in treating ITP.
Diagnosis When measuring the platelet count, one has to bear in mind that the "normal values" for laboratory measures are all statistical. They are defined by the upper and lower 2.5th percentile. It is therefore possible to be completely healthy but to have a decreased platelet count. There is, however, a higher chance of pathology. The diagnosis of ITP is a clinical one and is a diagnosis of exclusion. Low platelet count can be a feature of a large number of diseases and, when serious, warrants investigation by a hematologist. Secondary causes include leukemia, medications (e.g. quinine, heparin), lupus erythematosus and some other autoimmune disorders, cirrhosis (leading to thrombocytopenia from hypersplenism), HIV, congenital causes, and antiphospholipid syndrome. A bone marrow examination may be performed on patients over the age of 60 and people who do not respond to treatment, or when the diagnosis is in doubt. Hematology is the branch of medicine that is concerned with blood and its disorders. ...
Leukemia or leukaemia (see spelling differences) is a cancer of the blood or bone marrow and is characterized by an abnormal proliferation (production by multiplication) of blood cells, usually white blood cells (leukocytes). ...
Quinine (IPA: ) is a natural white crystalline alkaloid having antipyretic, anti-malarial with analgesic and anti-inflammatory properties and a bitter taste. ...
Heparin is a highly sulfated glycosaminoglycan widely used as an injectable anticoagulant. ...
Autoimmune diseases arise from an overactive immune response of the body against substances and tissues normally present in the body. ...
Cirrhosis is a consequence of chronic liver disease characterized by replacement of liver tissue by fibrotic scar tissue as well as regenerative nodules, leading to progressive loss of liver function. ...
Species Human immunodeficiency virus 1 Human immunodeficiency virus 2 Human immunodeficiency virus (HIV) is a retrovirus that causes acquired immunodeficiency syndrome (AIDS, a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections). ...
This article, image, template or category should belong in one or more categories. ...
A bone marrow biopsy is a medical procedure used as part of a test in the diagnosis of several conditions including leukemia. ...
Despite the destruction of platelets by splenic macrophages, the spleen is normally not enlarged. In fact, an enlarged spleen should lead a clinician to investigate other possible causes for the thrombocytopenia. Accelerated formation of platelets results in the presence of abnormally large platelets which are seen in a peripheral blood smear. Overall bleeding time is prolonged in these patients, but prothrombin time (PT) and partial thromboplastin time (PTT) are normal (because the problem is with the platelets, not with the coagulation cascade). A microscopic view of an abnormal blood film. ...
The prothrombin time (PT) and its derived measures of prothrombin ratio (PR) and international normalized ratio (INR) are measures of the extrinsic pathway of coagulation. ...
The partial thromboplastin time (PTT) or activated partial thromboplastin time (aPTT or APTT) is a performance indicator measuring the efficacy of both the intrinsic and the common coagulation pathways. ...
The coagulation cascade The coagulation cascade. ...
Occasionally, autoimmune hemolytic anemia and immune thrombocytic purpura may coexist, which is a condition called Evans syndrome. Evans Syndrome is an autoimmune disease in which an individuals antibodies attack their own RBCs as well as their platelets. ...
Treatment Mild ITP does not require treatment. When platelet counts fall under 10,000 per microliter, or under 50,000 when hemorrhage occurs (e.g. in the digestive tract or in a severe nosebleed) treatment is generally initiated with steroids. Intravenous immunoglobulin (IVIg) is often used initially in order to raise the count quickly. It is also a common treatment for children. When these strategies fail, splenectomy (removal of the spleen) is sometimes undertaken, as platelets targeted for destruction will often meet their fate in the spleen. Splenectomy is said to be successful in 60% of cases although it is less successful in older people. A relatively new strategy is treatment with anti-D, an agent used in mothers who have been sensitized to rhesus antigen by a Rh+ baby, but the patient must be Rh+. Immunosuppresants like mycophenolate mofetil and azathioprine are becoming more popular for their effectiveness. Rituximab has also been used with some success for some patients. A 250 ml bag of newly collected platelets. ...
This article is in need of attention. ...
To meet Wikipedias quality standards, this article or section may require cleanup. ...
For the Physics term GUT, please refer to Grand unification theory The gastrointestinal or digestive tract, also referred to as the GI tract or the alimentary canal or the gut, is the system of organs within multicellular animals which takes in food, digests it to extract energy and nutrients, and...
A nosebleed or nosebleedage, medically known as epistaxis, is the relatively common occurrence of hemorrhage (bleeding) from the nose, usually noticed when it drains out through the nostrils. ...
Steroid skeleton of lanosterol. ...
Intravenous immunoglobulin (IVIG) is a blood product administered intravenously. ...
A splenectomy is a procedure that involves the removal of the spleen by operative means. ...
In Greek mythology, King Rhesus of Thrace fought for Troy during the Trojan War. ...
Mycophenolic acid (INN) (IPA: ) or mycophenolate is an immunosuppressant drug used to prevent rejection in organ transplantation. ...
Azathioprine is a chemotherapy drug, now rarely used for chemotherapy but more for immunosuppression in organ transplantation, autoimmune disease such as rheumatoid arthritis or inflammatory bowel disease such as Crohns disease. ...
Rituximab, sold under the trade names Rituxan® and MabThera®, is a monoclonal antibody used in the treatment of B cell non-Hodgkins lymphoma, B cell leukemia, and some autoimmune disorders. ...
Extreme cases (very rare, especially rare in children) may require vincristine, a chemotherapy agent, to stop the immune system from destroying platelets. Vincristine (Oncovin®) is a vinca alkaloid from the Madagascar periwinkle (Catharanthus roseus, formerly Vinca rosea and hence its name). ...
Chemotherapy is the use of chemical substances to treat disease. ...
Intravenous immunoglobulin, while sometimes effective although not all patients respond, is expensive and the improvement is temporary (generally lasting less than a month). However, in the case of a pre-splenectomy ITP patient with dangerously low platelet counts, and a poor response to other treatments, IVIg treatment can increase platelet counts, making the splenectomy operation less dangerous. It is also commonly used as a long-term (though monthly) treatment. Intravenous immunoglobulin (IVIG) is a blood product administered intravenously. ...
Platelet transfusion is not normally recommended and is usually unsuccessful in raising a patient's platelet count. This is because the underlying autoimmune mechanism that destroyed the patient's platelets to begin with will also destroy donor platelets. An exception to this rule is when a patient is bleeding profusely, when transfusion of platelets can quickly form a platelet plug to stop bleeding. AMG 531 is an experimental treatment for stimulating platelet production. Initial clinical trials show it to be moderately effective in chronic ITP,[1] but its role in the treatment of ITP is still unknown, given that existing treatments are generally effective and that the underlying problem in ITP is the increased destruction of platelets, not their production.
Synonyms ITP knows many synonyms, but idiopathic or immunological thrombocytopenic purpura are the most common names. There's also an eponym, Werlhof's disease, but this is used infrequently. An eponym is the name of a person, whether real or fictitious, who has (or is thought to have) given rise to the name of a particular place, tribe, discovery, or other item. ...
Other synonyms include: essential thrombocytopenia, haemogenia, haemogenic syndrome, haemorrhagic purpura, idiopathic thrombopenic purpura, morbus haemorrhagicus maculosus, morbus maculosis haemorrhagicus, morbus maculosus werlhofii, peliosis werlhofi, primary splenic thrombocytopenia, primary thrombocytopenia, primary thrombocytopenic purpura, purpura haemorrhagica, purpura thrombocytopenica, purpura werlhofii, splenic thrombocytopenic purpura, thrombocytolytic purpura.
References - Cines DB, Blanchette VS (2002). "Immune thrombocytopenic purpura". N Engl J Med 346 (13): 995–1008. PMID 11919310.
- Cines D, Bussel J (2005). "How I treat idiopathic thrombocytopenic purpura (ITP)". Blood 106 (7): 2244–51. PMID 15941913. Review article, free full text
- Provan D, Newland A (2002). "Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory ITP in adults". Br J Haematol 118 (4): 933–44. PMID 2199770. Free fulltext.
- Coopamah M, Garvey M, Freedman J, Semple J (2003). "Cellular immune mechanisms in autoimmune thrombocytopenic purpura: An update". Transfus Med Rev 17 (1): 69–80. PMID 12522773.
- Semple JW and J Freedman. Enhanced anti platelet T lymphocyte reactivity in patients with autoimmune thrombocytopenia (ATP). Blood. 78(10):2619-2625, 1991.
- ITP Primer: ITP (idiopathic thrombocytopenic purpura, immune thrombocytopenic purpura). MediPrimer.com. Retrieved on 2007-02-14.
- Kumar, Vinay, Abul Abbas, and Nelson Fausto. Robins and Cotran Pathologic Basis of Disease, 7th ed. (2004). ISBN 81-8147-528-3
- Sacher, Ronald A. and Richard A. McPherson. Wildman's Clinical Interpretation of Laboratory Tests, 11th ed. (2000). ISBN 0-8036-0270-7
- Drug Induced Thrombocytopenia. Platelet Disorder Support Association. Retrieved on 2007-02-14.
- synd/3349 at Who Named It - Paul Gottlieb Werlhof
Hematological malignancy and White blood cells Lymphoid: Lymphocytic leukemia (ALL, CLL, HCL) • Lymphoma (Hodgkin's disease, NHL) • LPD • Myeloma (Multiple myeloma, Extramedullary plasmacytoma) The New England Journal of Medicine (NEJM) is a peer-reviewed medical journal published by the Massachusetts Medical Society with the highest impact factor for a general medical journal. ...
Blood is a bimonthly medical journal published by the American Society of Hematology. ...
2007 (MMVII) is the current year, a common year starting on Monday of the Gregorian calendar and the Anno Domini (common) era. ...
February 14 is the 45th day of the year in the Gregorian calendar. ...
2007 (MMVII) is the current year, a common year starting on Monday of the Gregorian calendar and the Anno Domini (common) era. ...
February 14 is the 45th day of the year in the Gregorian calendar. ...
Who Named It is a Norwegian database of several thousand eponymous medical signs and the doctors associated with their identification. ...
Pathology (from Greek pathos, feeling, pain, suffering; and logos, study of; see also -ology) is the study of the processes underlying disease and other forms of illness, harmful abnormality, or dysfunction. ...
Hematology is the branch of medicine that is concerned with blood and its disorders. ...
Although hematological malignancies are a form of cancer, they are generally treated by specialists in hematology, although in many hospitals oncology specialists also manage these diseases. ...
White blood cells or leukocytes are cells which form a component of the blood. ...
Wikipedia does not have an article with this exact name. ...
Leukemia or leukaemia (see spelling differences) is a cancer of the blood or bone marrow and is characterized by an abnormal proliferation (production by multiplication) of blood cells, usually white blood cells (leukocytes). ...
Acute lymphocytic leukaemia (ALL), also known as acute lymphoblastic leukaemia is a cancer of the white blood cells, characterised by the overproduction and continuous multiplication of malignant and immature white blood cells (referred to as lymphoblasts) in the bone marrow. ...
Chronic lymphocytic leukemia (or chronic lymphoid leukemia), known for short as CLL, is a type of leukemia in which too many lymphocytes are produced. ...
Hairy cell leukemia is a B cell neoplasm. ...
This article is about lymphoma in humans. ...
Hodgkins disease is a type of lymphoma described by Thomas Hodgkin in 1832, and characterized by the presence of Reed-Sternberg cells. ...
Non-Hodgkins lymphoma is a type of cancer. ...
Lymphoproliferative disorders (LPDs) refer to several conditions in which lymphocytes are produced in excessive quantities. ...
Multiple myeloma (also known simply as myeloma or plasma cell myeloma) is a hematological malignancy of plasma cells, the cells of the immune system that produce antibodies. ...
Multiple myeloma (also known as MM, myeloma, plasma cell myeloma, or as Kahlers disease after Otto Kahler) is a type of cancer of plasma cells which are immune system cells in bone marrow that produce antibodies. ...
Plasmacytoma refers to a malignant monoclonal plasma cell tumor growing either in bone or soft tissue. ...
Myeloid: Myelogenous leukemia (AML, CML) • MPD (Essential thrombocytosis, Polycythemia) • MDS • Myelofibrosis • Neutropenia Myeloid cells is a subsummating term for all hemopoietic cells except the lymphoid ones (T-cells, B-cells, NK-cells, dendritic cells). ...
Leukemia or leukaemia (see spelling differences) is a cancer of the blood or bone marrow and is characterized by an abnormal proliferation (production by multiplication) of blood cells, usually white blood cells (leukocytes). ...
Acute myelogenous leukemia (AML), also known as acute myeloid leukemia, is a cancer of the myeloid line of blood cells. ...
Chronic myelogenous leukemia (CML) is a form of chronic leukemia characterized by increased and unregulated clonal production of predominantly myeloid cells in the bone marrow. ...
The myeloproliferative diseases are a group of diseases of the bone marrow where excess cells are produced. ...
Essential thrombocytosis (ET, essential thrombocythemia) is a rare chronic blood disorder characterized by the overproduction of platelets by megakaryocytes (the precursor cell for platelets) in the absence of an alternative cause. ...
Polycythemia is a condition in which there is a net increase in the total number of red blood cells in the body. ...
The myelodysplastic syndromes (MDS, formerly known as preleukemia) are a diverse collection of hematological conditions united by ineffective production of blood cells and varying risks of transformation to acute myelogenous leukemia. ...
Myelofibrosis, one of the myeloproliferative diseases, is the gradual replacement of the bone marrow by connective tissue. ...
Neutropenia (or neutropaenia, adjective neutrop(a)enic) is a hematological disorder characterized by an abnormally low number of neutrophil granulocytes (a type of white blood cell). ...
Red blood cells Anemia • Hemochromatosis • Sickle-cell disease • Thalassemia • Hemolysis • Aplastic anemia • G6PD Deficiency • Hereditary spherocytosis • Hereditary elliptocytosis • Other hemoglobinopathies Human red blood cells Red blood cells are the most common type of blood cell and the vertebrate bodys principal means of delivering oxygen from the lungs or gills to body tissues via the blood. ...
Anemia (AmE) or anaemia (BrE), from the Greek () meaning without blood, refers to a deficiency of red blood cells (RBCs) and/or hemoglobin. ...
Haemochromatosis, also spelled hemochromatosis, is a hereditary disease characterized by improper processing by the body of dietary iron which causes iron to accumulate in a number of body tissues, eventually causing organ dysfunction. ...
Sickle-cell disease is a group of genetic disorders caused by sickle hemoglobin (Hgb S or Hb S). ...
Thalassemia (American English) or thalassaemia (British English) is a recessive trait inherited disease of the red blood cells. ...
Hemolysis (alternative spelling haemolysis) literally means the excessive breakdown of red blood cells. ...
Aplastic anemia is a condition where bone marrow does not produce sufficient new cells to replenish blood cells. ...
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked recessive hereditary disease featuring nonimmune hemolytic anemia in response to a number of causes. ...
Hereditary spherocytosis is a genetic disorder of the red blood cells that makes them prone to hemolysis. ...
Hereditary elliptocytosis is a blood disorder in which 50-90% of the red blood cells consist of rod forms and elliptocytes (that is, elliptical erythrocytes); often associated with a hemolytic anemia. ...
Hemoglobinopathy is a kind of genetic defect that results in abnormal structure of one of the globin chains of the hemoglobin molecule. ...
Coagulation and Platelets Thrombosis • Deep vein thrombosis • Pulmonary embolism • Hemophilia • ITP • TTP • DIC The coagulation of blood is a complex process during which blood forms solid clots. ...
A 250 ml bag of newly collected platelets. ...
Thrombosis is the formation of a clot or thrombus inside a blood vessel, obstructing the flow of blood through the circulatory system. ...
This article is about Deep-vein thrombosis. ...
Pulmonary embolism (PE) is blockage of the pulmonary artery (or one of its branches) by a blood clot, fat, air or clumped tumor cells. ...
This article does not cite its references or sources. ...
Thrombotic thrombocytopenic purpura (TTP or Moschcowitz disease) is a rare disorder of the blood coagulation system that in most cases arises from the deficiency or inhibition of the enzyme ADAMTS13, which is responsible for cleaving large multimers of von Willebrand factor. ...
Disseminated intravascular coagulation (DIC) is a pathological process in the body where the blood starts to coagulate throughout the whole body. ...
|